Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Directors’ Dealings News: Heidelberg Materials AG (EQS) +++ HEIDELBERG MATERIALS Aktie +3,54%

OLYMPUS Aktie

 >OLYMPUS Aktienkurs 
11.2225 EUR    (Tradegate)
Ask: 11.305 EUR / 443 Stück
Bid: 11.14 EUR / 449 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 8 bis 22 Uhr!
OLYMPUS Aktie über LYNX handeln
>OLYMPUS Performance
1 Woche: -3,6%
1 Monat: -0,4%
3 Monate: -11,5%
6 Monate: -24,0%
1 Jahr: -24,1%
laufendes Jahr: -22,6%
>OLYMPUS Aktie
Name:  OLYMPUS CORP.
Land:  Japan
Sektor:  Elektronik / Software
ISIN/ Wkn:  JP3201200007 / 856840
Symbol/ Ticker:  OLY1 (Frankfurt)
Kürzel:  FRA:OLY1, ETR:OLY1, OLY1:GR
Index:  Nikkei225
Webseite:  https://www.olympus-globa..
Marktkapitalisierung:  12900 Mio. EUR
Umsatz:  860832.15 Mio. EUR
EBITDA:  198728.6 Mio. EUR
Gewinn je Aktie:  0.535 EUR
Schulden:  197744.62 Mio. EUR
Liquide Mittel:  217967.92 Mio. EUR
Umsatz-/ Gewinnwachstum:  4.5% / 463.9%
KGV/ KGV lG:  18.47 / 19.46
KUV/ KBV/ PEG:  2.18 / 2.85 / 2.71
Gewinnm./ Eigenkapitalr.:  11.82% / 15.61%
Dividende je Aktie:  0.123 EUR
Dividendenrendite/ -schätzung:  1.1% / 3.21%
Div. Historie:  28.03.25 - 0.1226€
28.03.24 - 0.10998€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  OLYMPUS
Letzte Datenerhebung:  24.06.25
>OLYMPUS Eigentümer
Aktien: 1130 Mio. St.
f.h. Aktien: 1130 Mio. St.
Insider Eigner: 4.37%
Instit. Eigner: 59.54%
Leerverk. Aktien: -
 >OLYMPUS Anleihen 
Es sind 2 Anleihen zur OLYMPUS Aktie bekannt.
>OLYMPUS Peer Group

TDK
 
10.06.25 - 15:09
Olympus Announces Full Market Release of AI-Powered Emphysema Screening Program (PR Newswire)
 
SeleCT™ Screening Automatically Reviews Existing CT Scans to Help Identify Potential Emphysema Patients CENTER VALLEY, Pa., June 10, 2025 /PRNewswire/ -- Olympus Corp., a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced......
10.06.25 - 13:06
International Wire Group Acquires Hussey Copper (PR Newswire)
 
STAMFORD, Conn., June 10, 2025 /PRNewswire/ -- International Wire Group (IWG), a portfolio company of Olympus Partners and Atlas Holdings, entered into a definitive agreement to purchase Hussey Copper. Headquartered in Leetsdale, Pa., Hussey Copper is a market-leading supplier of copper......
30.05.25 - 07:12
Corporate News: Holcim Group Services Ltd (EQS)
 
Holcim breaks ground of OLYMPUS flagship project in Greece for near-zero cement...
29.05.25 - 15:36
Olympus Announces Launch of New Endoscope Drying Cabinet (PR Newswire)
 
ScopeLocker Air Offers Flexible Size and Air Options for Space-Conscious Facilities; Olympus to Highlight New Drying Cabinet at Annual SGNA Conference CENTER VALLEY, Pa., May 29, 2025 /PRNewswire/ -- Olympus Corp., a global medical technology company committed to making people's lives......
27.05.25 - 20:12
Olympus Announces FDA Clearance of Its Most Advanced Imaging Endoscopes (PR Newswire)
 
EDOF™ Technology Provides a Continuously Sharp Image with Minimal Focal Adjustment as Part of the EVIS X1™ Endoscopy System CENTER VALLEY, Pa., May 27, 2025 /PRNewswire/ -- Olympus, a global medical technology company committed to making people's lives healthier, safer and more......
22.05.25 - 20:54
AMA Establishes CPT Codes for Minimally Invasive ESD Procedure (PR Newswire)
 
CENTER VALLEY, Pa., May 22, 2025 /PRNewswire/ -- Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer, and more fulfilling, announced today the American Medical Association (AMA) Current Procedural Terminology (CPT®) Editorial Panel......
19.05.25 - 13:15
Olympus Appoints Slawek Kierner as Chief Digital Officer - Smart Connected Care (PR Newswire)
 
Newly created role to lead digital innovation TOKYO, May 19, 2025 /PRNewswire/ -- Olympus Corporation (Olympus), a global MedTech company committed to making people's lives healthier, safer and more fulfilling, today announced the appointment of Slawek Kierner to the role of Chief Digital......
13.05.25 - 13:24
Olympus Corp. Profit Retreats In Full Year (AFX)
 
TOKYO (dpa-AFX) - Olympus Corp. (OCPNY.PK) revealed earnings for full year that decreased from the same period last yearThe company's earnings came in at JPY117.855 billion, or JPY102.80 per share......
13.05.25 - 09:21
Olympus reports FY results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
01.05.25 - 19:51
Olympus Demonstrates New AI Endoscopy Solution at DDW® (PR Newswire)
 
The OLYSENSE Platform Aims to Strengthen Clinical Decision-Making by Leveraging Cloud-based Connectivity and AI Computing CENTER VALLEY, Pa., May 1, 2025 /PRNewswire/ -- Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling,......
27.04.25 - 22:06
OLYMPUS Long-Term Follow-Up Study Reports Nearly Four-Year Duration of Response in Subset of Patients with Low-Grade Upper Tract Urothelial Cancer Who Achieved a Complete Response to Initial JELMYTO Treatment (Business Wire)
 
Data Presented at the 2025 American Urological Association Annual Meeting in Las Vegas, Nevada PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights a duration of response of nearly four years from a long-term follow-up study with JELMYTO® (mitomycin) for pyelocalyceal solution, which is FDA-approved for the treatment of low-grade upper tract urothelial cancer (LG-UTUC) in adult patients. Among patients from the OLYMPUS trial who achieved a complete response after primary chemoablation with JELMYTO (n=41), the median duration of response was 47.8 months, irrespective of whether their cancer was new-onset or recurrent (median follow-up 28.1 months [95% CI 13.1, 57.5]). Of these patients, 21 had new-onset UTUC, and 20 had recurrent UTUC at baseline; there were no significant differences in durability between groups, with 8 patients in each group experien...
25.04.25 - 15:57
Corporate News: Olympus Corp. (EQS)
 
Olympus Appoints New CEO...
25.04.25 - 11:42
Japan′s Olympus names ex-Medtronic exec as new CEO (Nikkei)
 
Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...
25.04.25 - 10:42
Japan′s Olympus names Medtronic exec as new CEO (Nikkei)
 
Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...
25.04.25 - 09:00
Odfjell completes first near carbon-neutral transatlantic voyage using sails and biofuel, saving five tons of fuel every day and improving GHG intensity by 85% (Cision)
 
Odfjell's chemical tanker Bow Olympus is currently crossing the Atlantic powered by a combination of wind-assisted propulsion and a certified sustainable 100% biofuel. This milestone voyage proves how existing technologies and fuels can be paired to accelerate deep-sea shipping's transition to net zero emissions. Real-time data from the voyage confirms that this dual propulsion approach is not only technically feasible but also impactful: The vessel's GHG emissions on the current voyage meet the 2050 Fuel EU Maritime GHG intensity targets and IMO's GFI Direct Compliance targets at least...
24.04.25 - 08:12
EQT to acquire Olympus for $1.8bn (IntelliNews)
 
EQT has agreed to acquire the upstream and midstream assets of Olympus Energy for $1.8bn....
23.04.25 - 19:33
Eqt outlines $1B free cash flow and Olympus Energy acquisition impact in Q1 2025 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
22.04.25 - 23:18
EQT to buy Olympus Energy upstream, midstream assets in $1.8B cash and stock deal (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
11.04.25 - 19:42
All-New Subaru Motorsports USA WRX ARA25L to Debut at Olympus Rally (PR Newswire)
 
SHELTON, Wash., April 11, 2025 /PRNewswire/ -- The all-new WRX ARA25L from Subaru Motorsports USA makes its racing debut at Washington State's Olympus Rally this weekend. Piloted by extreme sports legend and Subaru Motorsports USA driver Travis Pastrana, the WRX ARA25L will compete within......
08.04.25 - 12:03
Monroe Capital Supports Olympus Partners′ Acquisition of PAI Pharma (Business Wire)
 
CHICAGO--(BUSINESS WIRE)--Monroe Capital LLC (“Monroe”) announced it acted as joint lead arranger on the funding of a senior credit facility to support the acquisition of PAI Pharma (“PAI”) by Olympus Partners. Founded in 1968 and based in Greenville, SC, PAI is a leading US oral generic liquids manufacturer of ready-to-dose cups and oral liquids bottles. PAI offers the broadest portfolio of generic oral liquid medicines in the industry, supporting retail chains, independent pharmacies, hospitals, long-term care facilities and government agencies. About Monroe Capital Monroe Capital LLC (“Monroe”) is a premier asset management firm specializing in private credit markets across various strategies, including direct lending, technology finance, venture debt, alternative credit solutions, structured credit, real estate and equity. Since 2004, the firm has been successfully providing capital solutions to clients in the U.S. and Canada. Monroe prides itself on being a value-added and user-friendly p...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Was man zu lang bedenkt, das wird bedenklich. - Sprichwort
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!